These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33803422)

  • 1. Stress and Nasal Allergy: Corticotropin-Releasing Hormone Stimulates Mast Cell Degranulation and Proliferation in Human Nasal Mucosa.
    Yamanaka-Takaichi M; Mizukami Y; Sugawara K; Sunami K; Teranishi Y; Kira Y; Paus R; Tsuruta D
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme.
    Ito N; Sugawara K; Bodó E; Takigawa M; van Beek N; Ito T; Paus R
    J Invest Dermatol; 2010 Apr; 130(4):995-1004. PubMed ID: 20043013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
    Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
    Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.
    D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ
    J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.
    Cao J; Papadopoulou N; Kempuraj D; Boucher WS; Sugimoto K; Cetrulo CL; Theoharides TC
    J Immunol; 2005 Jun; 174(12):7665-75. PubMed ID: 15944267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
    Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
    J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin and CRH interactions augment human mast cell activation.
    Alysandratos KD; Asadi S; Angelidou A; Zhang B; Sismanopoulos N; Yang H; Critchfield A; Theoharides TC
    PLoS One; 2012; 7(11):e48934. PubMed ID: 23155429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process.
    Donelan J; Boucher W; Papadopoulou N; Lytinas M; Papaliodis D; Dobner P; Theoharides TC
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7759-64. PubMed ID: 16682628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lentivirus-mediated CCR3 RNA interference on the function of mast cells of allergic rhinitis in mice.
    Wu S; Tang S; Peng H; Jiang Y; Liu Y; Wu Z; Liu Q; Zhu X
    Int Immunopharmacol; 2020 Jan; 78():106011. PubMed ID: 31776094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process.
    Pang X; Alexacos N; Letourneau R; Seretakis D; Gao W; Boucher W; Cochrane DE; Theoharides TC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):307-14. PubMed ID: 9765351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
    Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
    J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a New Exo-Endocytic Mechanism Triggered by Corticotropin-Releasing Hormone in Mast Cells.
    Balseiro-Gomez S; Flores JA; Acosta J; Ramirez-Ponce MP; Ales E
    J Immunol; 2015 Sep; 195(5):2046-56. PubMed ID: 26202981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
    Singh LK; Pang X; Alexacos N; Letourneau R; Theoharides TC
    Brain Behav Immun; 1999 Sep; 13(3):225-39. PubMed ID: 10469524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
    Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
    Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontline Science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology.
    Ayyadurai S; Gibson AJ; D'Costa S; Overman EL; Sommerville LJ; Poopal AC; Mackey E; Li Y; Moeser AJ
    J Leukoc Biol; 2017 Dec; 102(6):1299-1312. PubMed ID: 28684600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation.
    Dwyer DF; Ordovas-Montanes J; Allon SJ; Buchheit KM; Vukovic M; Derakhshan T; Feng C; Lai J; Hughes TK; Nyquist SK; Giannetti MP; Berger B; Bhattacharyya N; Roditi RE; Katz HR; Nawijn MC; Berg M; van den Berge M; Laidlaw TM; Shalek AK; Barrett NA; Boyce JA
    Sci Immunol; 2021 Feb; 6(56):. PubMed ID: 33637594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis.
    Le DD; Schmit D; Heck S; Omlor AJ; Sester M; Herr C; Schick B; Daubeuf F; Fähndrich S; Bals R; Frossard N; Al Kadah B; Dinh QT
    Neuroimmunomodulation; 2016; 23(5-6):261-270. PubMed ID: 28030866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.